The FDA released a new set of guidelines for potential coronavirus vaccines, noting that they must be at least 50% effective in a placebo-controlled trial.“While the FDA is committed to help expedite this work, we will not cut corners in our decision making and we are making clear in our guidance what are the data we need that should be submitted to meet our regulatory standards for approval,” said FDA Commissioner Stephen Hahn, MD. The race to bring a treatment and a vaccine from trials to market is underway, and Yourway has been there since the beginning of the pandemic, in support of all clinical trial needs.